Showing 6461-6470 of 18631 results for "".
Q&A: The Rise of Peptides
https://reachmd.com/programs/modern-aesthetics/QA-Rise-Peptides/32712/Kay Durairaj, MD, talks about the potential applications for peptides in aesthetic medicine, challenges in implementing them, and more.Skin Flooding: A Dermatologist’s Guide to the Latest Hydration Hack
https://reachmd.com/programs/modern-aesthetics/Skin-Flooding-Dermatologist-Guide-Latest-Hydration-Hack/32709/The ever-evolving world of social media throws up new skincare trends at a dizzying pace. One of the latest buzzwords is “skin flooding,” referring to a not-so-new technique that promises to deliver ultra-hydrated, plump skin. While this might pique the interest of your patients, being equipped withCanadian Perspective: Drs. Bhatia, Sapijaszko, and Kaufmann
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/canadian-perspective-drs-bhatia-sapijaszko-and-kaufmann/32695/Neal Bhatia, MD, speaks with Canadian Dermatology Association vice president Mariusz Sapijaszko, MD, FAACS, and former American Academy of Dermatology president Mark Kaufmann, MD, about different perspectives on advocacy in dermatology, including the use of patient stories.Skin of Color Session: Dr. Taylor
https://reachmd.com/programs/practical-dermatology/skin-of-color-session-dr-taylor/32674/Susan Taylor, MD, summarizes her presentation during the "Skin of Color Session" at Maui Derm 2025, including a discussion of photoprotection for patients with vitiligo, hyperpigmentation, and melasma.Psoriasis Update 2025: Dr. Gelfand
https://reachmd.com/programs/practical-dermatology/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.The Aryl Hydrocarbon Receptor and Lupus: Diagnostic and Therapeutic Advancements
https://reachmd.com/programs/living-rheum/the-aryl-hydrocarbon-receptor-and-lupus-diagnostic-and-therapeutic-advancements/28634/Explore the connection between the aryl hydrocarbon receptor and systemic lupus erythematosus and uncover its potential to improve treatment options.Pearls for Treating Atopic Skin
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-for-treating-atopic-skin/29483/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks with dermatologist James Del Rosso, DO, about different ways to treat patients with atopic dermatitis (AD), including using a well-made moisturizers, and also exploring both the science and the use of newer topical agents. ThisChronic Hand Eczema
https://practicaldermatology.com/series/updates-atopic-dermatitis/chronic-hand-eczema/29146/Dr. Raj Chovatiya, Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, talks about chronic hand eczema.Practices for Preventing Polypharmacy in Multiple Sclerosis
https://reachmd.com/programs/neurofrontiers/practices-for-preventing-polypharmacy-in-multiple-sclerosis/18045/Patients with multiple sclerosis are at increased risk of polypharmacy. Here are ways to prevent it in clinical practice.Are Disparities in Access to COVID-19 Testing Sites Skewing Case Estimates?
https://reachmd.com/programs/covid-19-frontlines/are-disparities-in-access-to-covid-19-testing-sites-skewing-case-estimates/11751/Many states and counties are turning to local data on COVID-19 incidence to help inform their next steps, but those reports might not be accurate.